Cipla Limited

NSEI:CIPLA Stock Report

Market Cap: ₹1.2t

Cipla Past Earnings Performance

Past criteria checks 5/6

Cipla has been growing earnings at an average annual rate of 19.7%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 9.2% per year. Cipla's return on equity is 15.7%, and it has net margins of 17%.

Key information

19.7%

Earnings growth rate

19.7%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate9.2%
Return on equity15.7%
Net Margin17.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Cipla Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Nov 01
Cipla Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Cipla Limited's (NSE:CIPLA) Share Price Could Signal Some Risk

Sep 29
Cipla Limited's (NSE:CIPLA) Share Price Could Signal Some Risk

Cipla (NSE:CIPLA) Is Increasing Its Dividend To ₹13.00

Jun 06
Cipla (NSE:CIPLA) Is Increasing Its Dividend To ₹13.00

Cipla's (NSE:CIPLA) Upcoming Dividend Will Be Larger Than Last Year's

May 21
Cipla's (NSE:CIPLA) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Update: Cipla Limited (NSE:CIPLA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

May 14
Earnings Update: Cipla Limited (NSE:CIPLA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

May 03
With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Feb 14
Is Cipla (NSE:CIPLA) Using Too Much Debt?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Jan 26
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Getting In Cheap On Cipla Limited (NSE:CIPLA) Is Unlikely

Jan 08
Getting In Cheap On Cipla Limited (NSE:CIPLA) Is Unlikely

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Nov 15
Is Cipla (NSE:CIPLA) Using Too Much Debt?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Oct 05
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Aug 04
Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Is Cipla (NSE:CIPLA) A Risky Investment?

Mar 24
Is Cipla (NSE:CIPLA) A Risky Investment?

A Look At The Fair Value Of Cipla Limited (NSE:CIPLA)

Mar 06
A Look At The Fair Value Of Cipla Limited (NSE:CIPLA)

Cipla (NSE:CIPLA) Has A Pretty Healthy Balance Sheet

Dec 11
Cipla (NSE:CIPLA) Has A Pretty Healthy Balance Sheet

Estimating The Fair Value Of Cipla Limited (NSE:CIPLA)

Aug 19
Estimating The Fair Value Of Cipla Limited (NSE:CIPLA)

Cipla (NSE:CIPLA) Will Pay A Dividend Of ₹5.00

Jul 30
Cipla (NSE:CIPLA) Will Pay A Dividend Of ₹5.00

Cipla (NSE:CIPLA) Could Easily Take On More Debt

Jul 14
Cipla (NSE:CIPLA) Could Easily Take On More Debt

If EPS Growth Is Important To You, Cipla (NSE:CIPLA) Presents An Opportunity

Jul 01
If EPS Growth Is Important To You, Cipla (NSE:CIPLA) Presents An Opportunity

Cipla Limited (NSE:CIPLA) Shares Could Be 34% Above Their Intrinsic Value Estimate

Apr 30
Cipla Limited (NSE:CIPLA) Shares Could Be 34% Above Their Intrinsic Value Estimate

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Mar 23
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Dec 18
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Revenue & Expenses Breakdown

How Cipla makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NSEI:CIPLA Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24262,64244,75157,3450
30 Jun 24258,92243,03556,1780
31 Mar 24255,36741,21654,9010
31 Dec 23251,16337,08253,7570
30 Sep 23243,40734,53252,5630
30 Jun 23235,10831,11251,2600
31 Mar 23225,59328,01950,1510
31 Dec 22222,18726,38348,9470
30 Sep 22218,87425,66048,1840
30 Jun 22216,10524,88435,9840
31 Mar 22217,07825,16846,6690
31 Dec 21210,71825,68143,2850
30 Sep 21207,61625,87643,0040
30 Jun 21202,80125,41742,4350
31 Mar 21191,20524,04941,2810
31 Dec 20188,77922,37440,4320
30 Sep 20180,80218,40339,4440
30 Jun 20174,37716,46238,8510
31 Mar 20170,80515,46538,6940
31 Dec 19171,20616,67838,6080
30 Sep 19167,57216,48938,3310
30 Jun 19163,73315,54637,8370
31 Mar 19163,23215,27737,4150
31 Dec 18155,22413,39135,6830
30 Sep 18154,28714,07435,0780
30 Jun 18154,99214,53034,5640
31 Mar 18151,05314,10534,1510
31 Dec 17147,61811,70132,9730
30 Sep 17144,95111,44432,7300
30 Jun 17141,63710,76232,8750
31 Mar 17143,34010,06433,0110
31 Dec 16142,50911,21331,5540
30 Sep 16137,54710,07131,0120
30 Jun 16134,33512,21930,0890
31 Mar 16135,48013,60029,2580
31 Dec 15135,04416,84739,0281,120
30 Sep 15131,63316,69438,2201,120
30 Jun 15124,78215,36837,0961,120
31 Mar 15113,45411,80823,5490
31 Dec 14106,19511,81832,1561,058
30 Sep 14105,62711,38331,3331,058
30 Jun 14104,16411,97630,2241,058
31 Mar 14101,73413,88429,5461,058
31 Dec 1394,33014,04225,122432

Quality Earnings: CIPLA has high quality earnings.

Growing Profit Margin: CIPLA's current net profit margins (17%) are higher than last year (14.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CIPLA's earnings have grown by 19.7% per year over the past 5 years.

Accelerating Growth: CIPLA's earnings growth over the past year (29.6%) exceeds its 5-year average (19.7% per year).

Earnings vs Industry: CIPLA earnings growth over the past year (29.6%) exceeded the Pharmaceuticals industry 20%.

Return on Equity

High ROE: CIPLA's Return on Equity (15.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y